Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi

Abstract

![Figure 1.][1] Figure 1. Kamuzu Central Hospital. ![Figure 2.][1] Figure 2. Median laboratory results for all patients receiving hydroxyurea (N = 130; range per month, 2-32). Error bars show interquartile range. View this table: Table 1. Characteristics of